Regenerex Pharma (RGPX) Share-based Compensation (2011 - 2025)

Regenerex Pharma (RGPX) has 7 years of Share-based Compensation data on file, last reported at $177867.0 in Q3 2025.

• Share-based Compensation for Q3 2025 came in at $177867.0, up 396.86% year-over-year; the trailing twelve-month figure through Sep 2025 was $510867.0 (up 328.37% YoY), and the FY2025 annual result was $132662.0, down 37.33% from the prior year.
• Share-based Compensation declined to $177867.0 in Q3 2025 per RGPX's latest filing, from $257133.0 in the prior quarter.
• Over five years, Share-based Compensation peaked at $257133.0 in Q2 2025 and troughed at $5400.0 in Q4 2023.
• A 3-year average of $76351.4 and a median of $46431.0 in 2024 frame the typical range for Share-based Compensation.
• The sharpest annual moves came in 2024 and 2025: Share-based Compensation plunged 63.78% in 2024, then jumped 1124.62% in 2025.
• A 3-year view of Share-based Compensation shows it stood at $5400.0 in 2023, then jumped by 232.83% to $17973.0 in 2024, then surged by 889.63% to $177867.0 in 2025.
• Business Quant data shows RGPX's Share-based Compensation at $177867.0 in Q3 2025, $257133.0 in Q2 2025, and $57894.0 in Q1 2025.